Best GLP-1 Providers for Postpartum Weight Loss in 2026 — Ranked & Reviewed
No GLP-1 medication has a labeled indication for postpartum weight loss, and none of the telehealth providers below specializes in postpartum care. The list below is the GLP-1 telehealth providers we partner with, carrying the same independent scores as on every other list; we may earn a commission when you sign up through them. If you are thinking about a GLP-1 after delivery, the questions that matter most are when to start, whether you are breastfeeding, and which contraception you use, and those belong in a conversation with your prescriber before you choose a provider.
Lowest verified price: $89/mo (2 providers: altRX and YourEra, lowest listed ongoing monthly price)43 providers compared
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
43 glp-1 providers for postpartum weight loss compared · independently scored against our six-factor methodology.
Before you compare: breastfeeding, timing and contraception
None of the GLP-1 labels declares the medication safe in lactation, and none contraindicates lactation either. Human lactation data are limited, so the labels ask prescribers to weigh the benefit to you against the infant's possible exposure case by case. The Mounjaro label reports a small study in which tirzepatide was undetectable in 164 of 171 breast-milk samples after a single 5 mg dose; it reports no data on effects on the breastfed infant or on milk production.
Tirzepatide can make birth control pills less effective. The Zepbound label says: “Advise patients using oral hormonal contraceptives to switch to a non-oral contraceptive method, or add a barrier method of contraception for 4 weeks after initiation with ZEPBOUND and for 4 weeks after each dose escalation.” If you might want another pregnancy soon, the semaglutide labels say to stop at least 2 months before a planned pregnancy. Your prescriber, your OB/GYN and, if you are breastfeeding, a lactation consultant should be part of the decision.
More detail: GLP-1s after pregnancy: the evidence, Mounjaro and breastfeeding, and the tirzepatide birth control warning.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
From /mo$79“starting at” priceFlat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide the lowest flat medication price if you can absorb an annual membership fee
From /mo$59+ required membershipFlat at every doseCoverage44 statesMedicationsSemaglutideTirzepatide- Nationwide Coverage
medication-included compounded GLP-1 from $169/mo on a 12-month prepaid plan, plus brand insurance help
From /mo$16912-month plan rateCoverage50 statesMedicationsSemaglutideTirzepatideOrforglipron lab-monitored compounded GLP-1 with mandatory video visit
From /mo$16912-month plan rateFlat at every doseCoverage39 statesMedicationsSemaglutideTirzepatidecompounded semaglutide or tirzepatide at one all-doses price on a yearly plan, with free shipping
From /mo$1,299entry-tier priceFlat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide- Best Budget
one flat compounded GLP-1 price at every dose: semaglutide $159/mo month to month, $119/mo on a 12-month plan
From /mo$159Flat at every doseCoverage50 statesMedicationsSemaglutideTirzepatide - Transparent Pricing
physician-led, pharmacy-transparent compounded GLP-1 with brand-name options
From /mo$249Coverage50 statesMedicationsSemaglutideTirzepatide compounded semaglutide and tirzepatide at a low starting price, with a full price list before you sign up
From /mo$200starting doseScales with doseCoverage48 statesMedicationsSemaglutideTirzepatide
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick lowest-price compounded semaglutide and tirzepatide with one flat price at every dose | $79“starting at” price Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
 the lowest flat medication price if you can absorb an annual membership fee | $59+ required membership Flat pricing | SemaglutideTirzepatide | 44 states | Visit → | |
Nationwide Coverage medication-included compounded GLP-1 from $169/mo on a 12-month prepaid plan, plus brand insurance help | $16912-month plan rate | SemaglutideTirzepatideOrforglipron | 50 states | Visit → | |
 lab-monitored compounded GLP-1 with mandatory video visit | $16912-month plan rate Flat pricing | SemaglutideTirzepatide | 39 states | Visit → | |
 compounded semaglutide or tirzepatide at one all-doses price on a yearly plan, with free shipping | $1,299entry-tier price Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
Best Budget one flat compounded GLP-1 price at every dose: semaglutide $159/mo month to month, $119/mo on a 12-month plan | $159 Flat pricing | SemaglutideTirzepatide | 50 states | Visit → | |
Transparent Pricing physician-led, pharmacy-transparent compounded GLP-1 with brand-name options | $249 | SemaglutideTirzepatide | 50 states | Visit → | |
 compounded semaglutide and tirzepatide at a low starting price, with a full price list before you sign up | $200starting dose Scales by dose | SemaglutideTirzepatide | 48 states | Visit → |
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
CoreAge Rx
Verified partnerBest for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
CoreAge Rx is an online clinic offering compounded semaglutide and tirzepatide, including low-dose microdosing plans, alongside longevity peptides, hormone therapy and skincare. Prescribing is handled by the MD Integrations physician groups. Semaglutide starts at $79/mo and tirzepatide at $129/mo, with the same price at every dose and free shipping.
Score Breakdown
Pros
- ✓Among the lowest compounded prices we track: semaglutide from $79/mo and tirzepatide from $129/mo
- ✓Same price at every dose, so your bill doesn't rise as your dose goes up
- ✓No membership fee; medication and shipping are included in the price
- ✓Displays a genuine LegitScript certification seal
- ✓Prescribing physicians are named for California, Massachusetts, Rhode Island and Vermont
- ✓Microdosing plans available at the same price as standard dosing
Cons
- ✗Trustpilot has suspended its rating for a breach of guidelines after removing a number of fake reviews
- ✗A 'Fall Sale' countdown timer showed nearly the same time left on two separate visits
- ✗The FAQ promises a 100% refund if not approved, but the refund policy deducts a $50-$100 consultation fee
- ✗The FAQ says 'no auto-rebills', yet the refund policy describes auto-renewing subscriptions
- ✗All orders become non-refundable 30 days after purchase, and you pay before a doctor reviews you
- ✗Partner pharmacies are not named; you have to call support to find out which one fills your order
- ✗Compounded only, with no brand-name Ozempic, Wegovy or Zepbound
- ✗The homepage FAQ still says semaglutide starts at $99/mo, which no longer matches the $79 product price
Collective
Verified partnerBest for: the lowest flat medication price if you can absorb an annual membership fee
Collective is a membership-based telehealth platform from the founder of Thrive Market, selling compounded semaglutide and tirzepatide at a flat price on every dose. Medication is billed separately from a required annual membership, and the program bundles unlimited clinician messaging, dietitian access and express cold shipping.
Score Breakdown
Pros
- ✓The lowest published compounded GLP-1 medication prices we track: $59/month semaglutide and $69/month tirzepatide
- ✓Flat pricing at every dose, so titrating up does not raise the bill
- ✓Unlimited doctor messaging, quarterly check-ins and registered-dietitian access are included rather than upsold
- ✓An optional twice-a-week dosing schedule and anti-nausea prescriptions when needed, aimed at the side effects that make people quit
- ✓21-day free membership trial, and a full refund if the doctor decides the medication isn't right for you
Cons
- ✗The advertised $59 and $69 exclude a mandatory $199 annual membership; the real first-year cost is $907 and $1,027
- ✗After the 21-day trial the membership fee is non-refundable and no partial-period refunds are given
- ✗Compounding pharmacies are described only as state-licensed US pharmacies and are never named
- ✗Not available in six states: Alabama, California, Louisiana, Massachusetts, Mississippi and Washington
Found
Verified partnerBest for: medication-included compounded GLP-1 from $169/mo on a 12-month prepaid plan, plus brand insurance help
Found is a weight-care membership that works with many insurance plans for clinical visits and offers a wide medication menu, including non-GLP-1 options. Compounded semaglutide and tirzepatide are included in the plan price: $169/mo cash or $99/mo with insurance on a 12-month plan paid upfront, or $289 and $199 on month-to-month plans billed every 28 days. Brand GLP-1s such as Wegovy, Zepbound and Foundayo are billed separately from the membership.
Score Breakdown
Pros
- ✓Compounded medication included in the plan price
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗The $169 cash rate is a 12-month plan paid upfront; month to month is $289
- ✗Month-to-month plans bill every 28 days, so a year is 13 charges, not 12
- ✗Brand-name GLP-1 medication is billed separately from the membership
Enhance MD
Verified partnerBest for: lab-monitored compounded GLP-1 with mandatory video visit
Enhance MD pairs compounded semaglutide and tirzepatide with mandatory baseline metabolic labs at Quest Diagnostics and a synchronous video visit with a board-certified clinician. That is a more rigorous onboarding than the async-only compounded GLP-1 model most telehealth providers use. Three tiers (Core semaglutide, Advanced tirzepatide, Elite combined) plus $100-off-first-order intro pricing ($112 first month on Core with code SUMMER100).
Score Breakdown
Pros
- ✓Baseline and ongoing metabolic labs (CMP, lipids, TSH, HbA1c) at Quest every 6 months, which is rare for compounded GLP-1
- ✓Mandatory video visit with a US-licensed MD or NP before your first prescription, not a pure questionnaire model
- ✓Three tiers, including a combined semaglutide + tirzepatide Elite plan ($322/mo) for patients plateaued on one GLP-1
- ✓Uses LegitScript-certified 503A pharmacies (Tru Meds Rx, Strive Pharmacy, Pharmacy Hub)
- ✓Intro pricing via $100 off your first order (code SUMMER100): $112 Core, $180 Advanced, $222 Elite first month
- ✓Unlimited clinician messaging and dose-adjustment support included
Cons
- ✗Compounded only, with no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
- ✗Not available in 10 states: AL, AR, GA, HI, LA, MS, MO, SC, TN, WV
- ✗Mandatory lab work adds 5–10 days to onboarding vs async-only competitors
- ✗No insurance accepted (cash pay, HSA/FSA eligible)
- ✗Intro discount covers only the first order; ongoing rates are $212–$322/mo on 12-month plans or $249–$379/mo month-to-month
Gala
Verified partnerBest for: compounded semaglutide or tirzepatide at one all-doses price on a yearly plan, with free shipping
Gala (legal entity AI Coaching Inc., d/b/a Gala GLP-1) is a women-focused telehealth platform selling compounded semaglutide from $129/mo, compounded tirzepatide at $179/mo with all doses included on a yearly subscription, and brand-name Ozempic at $1,299/mo. It claims licensed providers in all 50 states, free shipping, and a care team you can message seven days a week. An oral Wegovy pill is listed as 'coming soon.'
Score Breakdown
Pros
- ✓Compounded semaglutide from $129/mo and compounded tirzepatide at $179/mo with all doses included
- ✓Brand-name Ozempic available alongside the compounded options
- ✓Claims licensed providers in all 50 states, with free shipping included
- ✓Care team messaging seven days a week, plus advertised 24/7 patient support
- ✓FSA and HSA cards accepted for the compounded plan
- ✓LegitScript certified
Cons
- ✗The $179/mo tirzepatide rate requires a yearly subscription; no month-to-month price is published
- ✗Gala's own pages quote different figures ($129, $179 and $199 a month), so confirm your plan and total at checkout
- ✗Brand-name Ozempic at $1,299/mo is higher than at some peers
- ✗Pharmacy partners aren't named, only a "wide network of pharmacies"
- ✗No refund on cancellation unless a provider medically disqualifies you
- ✗Wegovy pill listed as "coming soon," not yet available
What to ask a GLP-1 provider after pregnancy
None of these providers is a postpartum specialist, so bring the postpartum questions to the prescriber yourself.
What to look for
- Breastfeeding. Tell the prescriber whether you are breastfeeding. GLP-1 labels neither establish safety in lactation nor rule it out, so this changes the conversation.
- Contraception. Tirzepatide can make birth control pills less effective, and its labels advise a non-oral or added barrier method for 4 weeks after starting and after each dose increase. Ask which method fits you.
- Plans for another pregnancy. The semaglutide labels say to stop at least 2 months before a planned pregnancy. Share your timeline so the prescriber can plan around it.
Red flags to avoid
- No named pharmacy or LegitScript listing. A legitimate compounded-GLP-1 provider names its 503A/503B pharmacy partner and carries LegitScript certification. If neither is disclosed, you can't verify what you're injecting.
- Async-only, no real clinician review. A prescriber should review your intake and be reachable for dose questions. Instant approval with no way to reach a clinician is a safety gap.
- Teaser pricing that hides the real cost. A low 'first month' price that jumps at higher doses, or a membership fee stacked on top of the medication, can double the true monthly total. Confirm the ongoing, all-in price before you pay.
- Weight-loss claims for B12, MIC, or HCG shots. Only GLP-1 injections have trial evidence for weight loss. A clinic selling B12, lipotropic, or HCG shots as a weight-loss treatment is a red flag.
Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Wegovy · Drugs and brands
- Zepbound · Drugs and brands
Sources & methodology (as of October 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.